Authors: | Modak, S.; Pandit-Taskar, N.; Kushner, B. H.; Kramer, K.; Smith-Jones, P.; Larson, S.; Cheung, N. K. V. |
Article Title: | Transient sialoadenitis: A complication of 131I- metaiodobenzylguanidine therapy |
Abstract: | Radioiodinated metaiodobenzylguanidine [131I-MIBG] is commonly used to treat resistant neuroblastoma or metastatic pheochromocytoma [MP] with little non-hematopoietic toxicity. We describe here transient sialoadenitis, a previously unreported complication. Ten patients [9 neuroblastoma and 1 MP] received 12-18 mCi/kg of 131I-MIBG. Five patients had bilateral parotid swelling, two with associated buccal discomfort within 24 hr of injection which subsided within 48 hr. Grade 3 or 4 serum amylase elevation was documented in 8/8 patients tested [median 1,336; range: 576-8,830 U/L] which normalized [25-125 U/L] within 4-14 [median 5.5] days. Serum lipase remained normal. Patients did not develop subsequent dry mouth or dysphagia. © 2007 Wiley-Liss, Inc. |
Keywords: | adolescent; child; clinical article; controlled study; child, preschool; side effect; antineoplastic agents; cancer radiotherapy; radiopharmaceuticals; dysphagia; neuroblastoma; 3-iodobenzylguanidine; xerostomia; erythema; single drug dose; nausea and vomiting; (3 iodobenzyl)guanidine i 131; pheochromocytoma; amylase blood level; triacylglycerol lipase blood level; liothyronine; amylase; amylases; triacylglycerol lipase; sialoadenitis; sialadenitis; hyperamylasemia; salivation; malignant pheochromocytoma; mibg therapy; chewing discomfort; facial discomfort; jaw pain; parotid enlargement; parotid swelling |
Journal Title: | Pediatric Blood and Cancer |
Volume: | 50 |
Issue: | 6 |
ISSN: | 1545-5009 |
Publisher: | Wiley Periodicals, Inc |
Date Published: | 2008-06-01 |
Start Page: | 1271 |
End Page: | 1273 |
Language: | English |
DOI: | 10.1002/pbc.21391 |
PUBMED: | 17973318 |
PROVIDER: | scopus |
DOI/URL: | |
Notes: | --- - "Cited By (since 1996): 5" - "Export Date: 17 November 2011" - "CODEN: PBCEA" - "Source: Scopus" |